Search
Menu
Home
HTB
2002
September
September 2002
Contents
On the web
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
Insights into HIV-specific CD4+ T cell immunity
Cytomegalovirus: update
The switching spiral: a triumph of hope over benefit?
Peripheral neuropathy
The push for once-daily HAART: a call for caution
Enhancing adherence to antiretrovirals: strategies and regimens
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
HAART and prevention of HIV transmission
PDFs
Volume 3 Number 7 August/September 2002 PDF
Post navigation
Newer articles
HTB RSS
Early access
US CDC updated guidelines on PEP (May 2025)
10 May 2025
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate